552 related articles for article (PubMed ID: 26631032)
21. The expression and significance of the enhancer of zeste homolog 2 in lung adenocarcinoma.
Lv Y; Yuan C; Xiao X; Wang X; Ji X; Yu H; Wu Z; Zhang J
Oncol Rep; 2012 Jul; 28(1):147-54. PubMed ID: 22552406
[TBL] [Abstract][Full Text] [Related]
22. EZH2-induced H3K27me3 is associated with epigenetic repression of the ARHI tumor-suppressor gene in ovarian cancer.
Fu Y; Chen J; Pang B; Li C; Zhao J; Shen K
Cell Biochem Biophys; 2015 Jan; 71(1):105-12. PubMed ID: 25077680
[TBL] [Abstract][Full Text] [Related]
23. Oridonin effectively reverses cisplatin drug resistance in human ovarian cancer cells via induction of cell apoptosis and inhibition of matrix metalloproteinase expression.
Ma S; Tan W; Du B; Liu W; Li W; Che D; Zhang G
Mol Med Rep; 2016 Apr; 13(4):3342-8. PubMed ID: 26935490
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional suppression of Dicer by HOXB-AS3/EZH2 complex dictates sorafenib resistance and cancer stemness.
Tseng CF; Chen LT; Wang HD; Liu YH; Shiah SG
Cancer Sci; 2022 May; 113(5):1601-1612. PubMed ID: 35253323
[TBL] [Abstract][Full Text] [Related]
25. The role of Sp1 and EZH2 in the regulation of LMX1A in cervical cancer cells.
Lin WC; Yan MD; Yu PN; Li HJ; Kuo CC; Hsu CL; Lin YW
Biochim Biophys Acta; 2013 Dec; 1833(12):3206-3217. PubMed ID: 24018208
[TBL] [Abstract][Full Text] [Related]
26. miR‑519d‑3p/HIF‑2α axis increases the chemosensitivity of human cervical cancer cells to cisplatin via inactivation of PI3K/AKT signaling.
Jiang L; Shi S; Li F; Shi Q; Zhong T; Zhang H; Xia Y
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760204
[TBL] [Abstract][Full Text] [Related]
27. EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repair.
Koyen AE; Madden MZ; Park D; Minten EV; Kapoor-Vazirani P; Werner E; Pfister NT; Haji-Seyed-Javadi R; Zhang H; Xu J; Deng N; Duong DM; Pecen TJ; Frazier Z; Nagel ZD; Lazaro JB; Mouw KW; Seyfried NT; Moreno CS; Owonikoko TK; Deng X; Yu DS
Oncogene; 2020 Jun; 39(25):4798-4813. PubMed ID: 32457468
[TBL] [Abstract][Full Text] [Related]
28. EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers.
Au SL; Wong CC; Lee JM; Wong CM; Ng IO
PLoS One; 2013; 8(6):e68226. PubMed ID: 23826380
[TBL] [Abstract][Full Text] [Related]
29. PRIMA-1, a mutant p53 reactivator, restores the sensitivity of TP53 mutant-type thyroid cancer cells to the histone methylation inhibitor 3-Deazaneplanocin A.
Cui B; Yang Q; Guan H; Shi B; Hou P; Ji M
J Clin Endocrinol Metab; 2014 Jun; 99(6):E962-70. PubMed ID: 24512488
[TBL] [Abstract][Full Text] [Related]
30. [Inhibiting HSP70 expression enhances cisplatin sensitivity of cervical cancer cells].
Liu J; Liu J; Li SZ; Zheng YA; Guo SY; Wang X
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 37(4):475-481. PubMed ID: 28446399
[TBL] [Abstract][Full Text] [Related]
31. [Cisplatin inhibits proliferation of cervical carcinoma cell line by up-regulating Stat1 expression].
Lei RL; Xiao SS; Xue M
Nan Fang Yi Ke Da Xue Xue Bao; 2015 Jan; 35(1):88-92. PubMed ID: 25613616
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-137 is negatively associated with clinical outcome and regulates tumor development through EZH2 in cervical cancer.
Zhang H; Yan T; Liu Z; Wang J; Lu Y; Li D; Liang W
J Cell Biochem; 2018 Jan; 119(1):938-947. PubMed ID: 28681918
[TBL] [Abstract][Full Text] [Related]
33. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
[TBL] [Abstract][Full Text] [Related]
34. HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2.
Ye Y; Yang S; Han Y; Sun J; Xv L; Wu L; Ming L
Open Biol; 2019 Sep; 9(9):190068. PubMed ID: 31551012
[TBL] [Abstract][Full Text] [Related]
35. 3-deazaneplanocin A protects against cisplatin-induced renal tubular cell apoptosis and acute kidney injury by restoration of E-cadherin expression.
Ni J; Hou X; Wang X; Shi Y; Xu L; Zheng X; Liu N; Qiu A; Zhuang S
Cell Death Dis; 2019 May; 10(5):355. PubMed ID: 31043583
[TBL] [Abstract][Full Text] [Related]
36. Silencing the EZH2 gene by RNA interference reverses the drug resistance of human hepatic multidrug-resistant cancer cells to 5-Fu.
Zhang Y; Liu G; Lin C; Liao G; Tang B
Life Sci; 2013 May; 92(17-19):896-902. PubMed ID: 23562851
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of miR-138 Increases Sensitivity to Cisplatin in Hepatocellular Carcinoma by Regulating EZH2.
Zeng T; Luo L; Huang Y; Ye X; Lin J
Biomed Res Int; 2021; 2021():6665918. PubMed ID: 33748276
[TBL] [Abstract][Full Text] [Related]
38. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line.
Du P; Zhang X; Liu H; Chen L
DNA Cell Biol; 2015 Jul; 34(7):497-502. PubMed ID: 25941922
[TBL] [Abstract][Full Text] [Related]
39. Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein.
Holland D; Hoppe-Seyler K; Schuller B; Lohrey C; Maroldt J; Dürst M; Hoppe-Seyler F
Cancer Res; 2008 Dec; 68(23):9964-72. PubMed ID: 19047178
[TBL] [Abstract][Full Text] [Related]
40. Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer.
Wang T; Liu Z; Shi F; Wang J
Mol Cell Biochem; 2016 Feb; 413(1-2):179-87. PubMed ID: 26820938
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
